Dissimilar courses of twins with leukemia

Area of Science:

• Pediatric Oncology
• Hematology
• Genetics

Background:

• Identical twins share the same genetic makeup, making them valuable for studying environmental versus genetic influences on disease.
• Acute lymphocytic leukemia (ALL) is a common childhood cancer, but its presentation and progression can vary significantly.

Observation:

• Two genetically identical twin sisters presented with acute lymphocytic leukemia (ALL) six years apart.
• Despite similar initial clinical presentations, the twins received markedly different therapeutic regimens.
• The first twin experienced multiple relapses and remissions, ultimately succumbing to the disease after 34 months, while the second twin has remained disease-free for 60 months.

Findings:

• The divergent clinical courses suggest that distinct leukemogenic events, rather than solely genetic predisposition, may have initiated leukemia in each twin.
• The comprehensive treatment protocol for the second twin, including multi-agent chemotherapy and central nervous system prophylaxis, likely contributed to her long-term remission.
• The first twin's outcome was associated with a less intensive single-drug maintenance therapy.

Implications:

• This case underscores the critical role of diverse therapeutic strategies in managing acute lymphocytic leukemia, even in genetically identical individuals.
• Environmental factors and specific leukemogenic events may play a more significant role in ALL pathogenesis and progression than previously assumed.
• Further research into the specific leukemogenic pathways and optimal treatment combinations for ALL is warranted.